Cargando…
Frequency of CHEK2 mutations in a population based, case–control study of breast cancer in young women
INTRODUCTION: The cell-cycle checkpoint kinase (CHEK)2 protein truncating mutation 1100delC has been associated with increased risk for breast or prostate cancer. Multiple studies have found an elevated frequency of the 1100delC variant in specific stratifications of breast cancer patients with a fa...
Autores principales: | Friedrichsen, Danielle M, Malone, Kathleen E, Doody, David R, Daling, Janet R, Ostrander, Elaine A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1064080/ https://www.ncbi.nlm.nih.gov/pubmed/15535844 http://dx.doi.org/10.1186/bcr933 |
Ejemplares similares
-
Vitamin D receptor polymorphisms and breast cancer risk in a large population-based case-control study of Caucasian and African-American women
por: Trabert, Britton, et al.
Publicado: (2007) -
The risk of breast cancer in women with a CHEK2 mutation
por: Cybulski, Cezary, et al.
Publicado: (2012) -
Frequency of the CHEK2 1100delC mutation among women with early-onset and bilateral breast cancer
por: Ding, Dapeng, et al.
Publicado: (2012) -
Population Screening of CHEK2 Mutations in Poland
por: Cybulski, Cezary, et al.
Publicado: (2006) -
Current perspectives on CHEK2 mutations in breast cancer
por: Apostolou, Panagiotis, et al.
Publicado: (2017)